Vol 7, Supplement 1 (March 27, 2019): Annals of Translational Medicine

Editorial Commentary

Patient centered care for prostate cancer—how can artificial intelligence and machine learning help make the right decision for the right patient?
Nathan C. Wong, Bobby Shayegan
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S1
Meningeal lymphatics in aging and Alzheimer’s disease
Russell J. Jaffe, Rajnish S. Dave, Siddappa N. Byrareddy
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S2
Pembrolizumab in advanced gastric cancer: pioneering or prosaic?
Sarbajit Mukherjee, Steven N. Hochwald
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S3
Improving detection combined with targeted therapy for small hepatocellular carcinoma
Shengyang Qiu, Long R. Jiao
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S4
Is the onset of adverse effects of immunotherapy always bad news for the patients…?—certainly not!
Paul Hofman
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S5
Fluorescence-guided surgery in cancer treatment: current status and future perspectives
Yongchang Zheng, Huayu Yang, Henan Wang, Kai Kang, Wenkai Zhang, Gang Ma, Shunda Du
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S6
Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?
Andre P. Fay, Emmanuel S. Antonarakis
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S7
Pathophysiology of pain in patients with peritoneal endometriosis
Simone Ferrero, Valerio Gaetano Vellone, Fabio Barra
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S8
Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment
Alex B. Blair, Vincent P. Groot, Jin He
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S9
American Joint Committee on Cancer 8th edition staging—an improvement in prognostication in HPV-associated oropharyngeal cancer?
Jon Mallen-St Clair, Allen S. Ho
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S10
Eighth edition of the American Joint Committee on Cancer staging system for soft tissue sarcoma of the trunk and extremity: in search of a better staging system
Kazuhiro Tanaka, Hiroshi Tsumura
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S11
Cancer staging for rare cancers: should the American Joint Committee on Cancer have a separate staging classification for external auditory canal cancer?
Jonathan Robert Clark, Hubert Low, Ruta Gupta
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S12
Mitochondrial cytochrome c oxidase is not the primary acceptor for near infrared light—it is mitochondrial bound water: the principles of low-level light therapy
Andrei P. Sommer
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S13
Pembrolizumab for recurrent/metastatic head and neck cancer: equally promising for Asian patients?
Wenda Ye, Nicole C. Schmitt
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S14
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all?
Camillo Porta, Laura Cosmai, Mimma Rizzo, Mario Melazzini
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S15
Ultrasound patterns of pulmonary edema
Gino Soldati, Marcello Demi, Libertario Demi
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S16
There is another new method for cryopreserving small numbers of human sperm cells
Alessio Paffoni, Simone Palini
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S17
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement
Umang Swami, Roberto H. Nussenzveig, Benjamin Haaland, Neeraj Agarwal
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S18
Monocyte-platelet cross-talk in peripheral artery disease—how much does the pathogenesis of atherosclerosis depend on anatomical location?
Richard A. Brown, Gregory Y. H. Lip
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S19
The variables of force generation and application to cartilage, ligaments and bone remain to be defined
Robert A. Teitge
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S20
Orphan noncoding RNAs: novel regulators and cancer biomarkers
Mona Teng, Lydia Y. Liu, Junjie Tony Hua, Sujun Chen, Housheng Hansen He
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S21
Immunotherapeutic strategies in patients with advanced head and neck squamous cell carcinoma
Maysaloun Merhi, Afsheen Raza, Varghese Inchakalody, Abdul Rahman Zar, Shahab Uddin, Said Dermime
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S22
Important caveats of KEYNOTE-045: relevance of these findings in the current and future therapeutic paradigm
Julio Slongo, Rohit K. Jain, Philippe E. Spiess
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S23
The use of baseline tumor size to prognosticate overall survival in stage IV melanoma patients treated with the PD-1 inhibitor pembrolizumab
Philip Friedlander
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S24
Norepinephrine, more than a vasopressor
Emilio Daniel Valenzuela Espinoza, Glenn Hernandez, Jan Bakker
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S25
A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy: an editorial comment
Joyce Wong
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S26
Electronic health records, physician workflows and system change: defining a pathway to better healthcare
Carla M. Pugh
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S27
Nephron repair: powered by anaerobic energy metabolism
Brooke E. Chambers, Rebecca A. Wingert
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S28
Nanoparticles as theranostic vehicles in prostate cancer
Rafael Morales-Barrera, Cristina Suárez, Joaquín Mateo, Macarena González, Joan Carles
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S29
Mind the gap: renal tubule responses to injury and the role of Cxcl12 and Myc
Veronika Sander, Richard W. Naylor, Alan J. Davidson
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S30
Anterior knee pain as a functional problem of complex dynamic inter-play of living structures
Werner Müller
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S31
Is an immune checkpoint inhibitor really a hopeless therapeutic choice for EGFR-mutant non-small cell lung cancer (NSCLC) patients?
Kei Kunimasa, Kazumi Nishino, Toru Kumagai
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S32
Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system
Hiren V. Patel, Arnav Srivastava, Brian Shinder, Evita Sadimin, Eric A. Singer
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S33
Anatomy is not enough: the crucial role of biology and genetics in AJCC eighth edition of the TNM classification for breast cancer
Francesca Magnoni, Giuseppe Accardo, Elisabetta Rossi, Paolo Veronesi, Giovanni Corso
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S34
When survival curves cross: are we at a crossroads of immunotherapy in gastric cancer?
Jun Gong, Joseph Chao
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S35
Editorial on “Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era”
Yasmin Abu-Ghanem, Jacob Ramon
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S36
The potential role of germline single nucleotide polymorphisms for selecting the ideal candidates for sunitinib therapy in patients with locally-advanced renal cell carcinoma
Alberto Martini, Reza Mehrazin
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S37
Adjuvant therapy in renal cell carcinoma—is pharmacogenomics assessment another element to select our patients?
Vincenzo Di Nunno, Veronica Mollica, Lidia Gatto, Matteo Santoni, Giulia Sorgentoni, Nicola Battelli, Francesco Massari
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S38
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma
Matteo Santoni, Giada Maiorani, Luca Faloppi, Vincenzo Di Nunno, Lidia Gatto, Francesco Massari, Nicola Battelli
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S39
Stem cell therapy in diabetic men with erectile dysfunction: a step closer to safe and effective regenerative technology
Eric Chung
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S40
UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classifications for patients treated with radical prostatectomy: reliable but not infallible prognostic tools
Marco Bandini, Felix Preisser
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S41
Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer
Marcos Magalhães Filho, Pedro N. Aguiar Jr, Ramon Andrade de Mello
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S42
Fine-tuning autophagy in pancreatic adenocarcinoma: full blockage is required
Nicolas Jonckheere, Isabelle Van Seuningen
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S43
Is smoking causally-associated with hepatitis B virus-related hepatocellular carcinoma?
Kyrillus S. Shohdy, Omar Abdel-Rahman
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S44
Predicting renal function after kidney cancer surgery: a tool for clinical decision making
Natalie R. Swavley, Alessandro Veccia, Riccardo Autorino
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S45
Potential biological and clinical benefit of prostate-directed interventions in patients with metastatic prostate cancer
Makito Miyake, Takuya Owari, Nobumich Tanaka, Kiyohide Fujimoto
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S46
What is the most durable construct for a forefoot amputation, traditional transmetatarsal amputation or a medial ray sparing procedure?
Lawrence A. Lavery, Peter A. Crisologo, Metin Yavuz
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S47
Systemic therapy of elderly patients with advanced non-small cell lung cancer—individualized treatment is key
Robert Pirker
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S48
Thyroid cancer staging and genomics
Ashok R. Shaha, R. Michael Tuttle
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S49
Encouraging early outcomes in cancer and leukemia group B (CALGB)/Alliance 140503: patient selection, not extent of resection, is the key to perioperative success
Kyle G. Mitchell, Mara B. Antonoff
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S50
Implementation of staging systems in clinical practice for cutaneous squamous cell carcinoma
Javier Cañueto
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S51
Eighth edition of the American Joint Committee on Cancer staging system: are we getting closer to the ideal classification for gastric cancer?
Karen Elizabeth Padilla-Leal, Heriberto Medina-Franco
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S52
An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
Muhammad Zubair Afzal, Konstantin H. Dragnev, Keisuke Shirai
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S53
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions
Melissa Bersanelli, Sebastiano Buti, Matteo Santoni, Francesco Ziglioli, Umberto Maestroni
Annals of Translational Medicine
 2019;
7
(Suppl 1)
:S54

Disclosure:

The supplement was published without any sponsorship or funding.